Log D 7.4 and plasma protein binding of synthetic cannabinoid receptor agonists and a comparison of experimental and predicted lipophilicity
Drug Testing and Analysis · 2024-09 · 16 (9) · 1012-1025
DOI: 10.1002/dta.3621 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Drug Testing and Analysis, online erschienen am 08.12.2023. Verfasst von Andrew M Brandon und 9 weiteren Autor:innen. Beteiligte Einrichtung: Leverhulme Research Centre for Forensic Science, School of Science and Engineering, University of Dundee, Dundee, UK. Hauptthemen laut MEDLINE: Cannabinoid Receptor Agonists, Hydrophobic and Hydrophilic Interactions, Protein Binding. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Engineering and Physical Sciences Research Council, Leverhulme Trust.
Abstract (Originalsprache)
The emergence of new synthetic cannabinoid receptor agonists (SCRAs) onto the illicit drugs market continues to cause harm, and the overall availability of physicochemical and pharmacokinetic data for new psychoactive substances is lacking. The lipophilicity of 23 SCRAs and the plasma protein binding (PPB) of 11 SCRAs was determined. Lipophilicity was determined using a validated chromatographic hydrophobicity index (CHI) log D method; tested SCRAs showed moderate to high lipophilicity, with experimental log D 7.4 ranging from 2.48 (AB‐FUBINACA) to 4.95 (4F‐ABUTINACA). These results were also compared to in silico predictions generated using seven commercially available software packages and online tools (Canvas; ChemDraw; Gastroplus; MoKa; PreADMET; SwissADME; and XlogP). Licenced, dedicated software packages provided more accurate lipophilicity predictions than those which were free or had prediction as a secondary function; however, the latter still provided competitive estimates in most cases. PPB of tested SCRAs, as determined by equilibrium dialysis, was in the upper range of the lipophilicity scale, ranging from 90.8% (ADB‐BUTINACA) to 99.9% (BZO‐HEXOXIZID). The high PPB of these drugs may contribute to reduced rate of clearance and extended durations of pharmacological effects compared to lesser‐bound SCRAs. The presented data improve understanding of the behaviour of these drugs in the body. Ultimately, similar data and predictions may be used in the prediction of the structure and properties of drugs yet to emerge on the illicit market.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Leverhulme Research Centre for Forensic Science, School of Science and Engineering, University of Dundee, Dundee, UK.
- Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK.
- Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dundee, UK.
- Debiopharm, Lausanne, Switzerland.
- Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, Linköping, Sweden.
- Division of Clinical Chemistry and Pharmacology, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden.
ORCID-Profile: Steven R Baginski, Henrik Green, Oliver B Sutcliffe, Niamh Nic Daéid, Lorna A Nisbet
Förderung
- Engineering and Physical Sciences Research Council
- Leverhulme Trust
Zitieren
APA
Brandon, A. M., Baginski, S. R., Peet, C., Dugard, P., Green, H., Sutcliffe, O. B., Daéid, N. N., Nisbet, L. A., Read, K. D., & McKenzie, C. (2024). Log D 7.4 and plasma protein binding of synthetic cannabinoid receptor agonists and a comparison of experimental and predicted lipophilicity. Drug Testing and Analysis, 16(9), 1012-1025. https://doi.org/10.1002/dta.3621
Vancouver
Brandon AM, Baginski SR, Peet C, Dugard P, Green H, Sutcliffe OB, et al. Log D 7.4 and plasma protein binding of synthetic cannabinoid receptor agonists and a comparison of experimental and predicted lipophilicity. Drug Testing and Analysis. 2024;16(9):1012-1025. doi:10.1002/dta.3621
BibTeX
@article{Brandon2024,
author = {Brandon, Andrew M and Baginski, Steven R and Peet, Caroline and Dugard, Pat and Green, Henrik and Sutcliffe, Oliver B and Daéid, Niamh Nic and Nisbet, Lorna A and Read, Kevin D and McKenzie, Craig},
title = {Log D 7.4 and plasma protein binding of synthetic cannabinoid receptor agonists and a comparison of experimental and predicted lipophilicity},
journal = {Drug Testing and Analysis},
year = {2024},
volume = {16},
number = {9},
pages = {1012--1025},
doi = {10.1002/dta.3621}
}
EUVIMED